Details of the Drug Reposition

General Information of This Drug (ID: DMR87TR)

• Drug Name: Etrolizumab (DMR87TR)

Information on Drug Reposition of This Drug

2 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Crohn disease	DIS2C5Q8	DD70	Phase 3	[1]
Ulcerative colitis	DIS8K27O	DD71	Phase 3	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)